Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barretts esophagus: a meta-analysis

摘要

Background: Esophageal adenocarcinoma (EAC) has high mortality and is increasing in incidence. Barrett's esophagus (BE) increases the risk for EAC. Studies have reported inconsistent findings on the association between use of cyclooxygenase (COX) inhibitors and the risk of neoplastic progression in BE patients. Therefore, we performed a meta-analysis to investigate this association.